Journal article
Recognition of the nonclassical MHC class i molecule H2-M3 by the receptor Ly49A regulates the licensing and activation of NK cells
DM Andrews, LC Sullivan, N Baschuk, CJ Chan, R Berry, CL Cotterell, J Lin, H Halse, SV Watt, J Poursine-Laurent, CR Wang, AA Scalzo, WM Yokoyama, J Rossjohn, AG Brooks, MJ Smyth
Nature Immunology | NATURE PUBLISHING GROUP | Published : 2012
DOI: 10.1038/ni.2468
Abstract
The development and function of natural killer (NK) cells is regulated by the interaction of inhibitory receptors of the Ly49 family with distinct peptide-laden major histocompatibility complex (MHC) class I molecules, although whether the Ly49 family is able bind to other MHC class I-like molecules is unclear. Here we found that the prototypic inhibitory receptor Ly49A bound the highly conserved nonclassical MHC class I molecule H2-M3 with an affinity similar to its affinity for H-2D d. The specific recognition of H2-M3 by Ly49A regulated the 'licensing' of NK cells and mediated 'missing-self' recognition of H2-M3-deficient bone marrow. Host peptide-H2-M3 was required for optimal NK cell ac..
View full abstractGrants
Awarded by Howard Hughes Medical Institute
Funding Acknowledgements
We thank C. Paget for critical analysis of the manuscript; E. Hawkins, Q. Mundrea, B. Venville, N. McLaughlin and J. Sharkey for technical assistance; and B. Murphy (UC Davis Cancer Center) for the YE1/32 antibody to Ly49A. Supported by the National Health and Medical Research Council of Australia (D.M.A., L.C.S., R.B., M.J.S., A.G.B. and J.R.), Cancer Australia, the Cure Cancer Australia Foundation, the US National Institutes of Health (AI040310 to C.-R.W.) and the Howard Hughes Medical Institute (W.M.Y.).